BLRX
BioLineRx Ltd. American Depositary Shares (BLRX)
$51
About BioLineRx Ltd. American Depositary Shares (BLRX)
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Details
Daily high
$3.60
Daily low
$3.50
Price at open
$3.60
52 Week High
$35.60
52 Week Low
$2.30
Market cap
13.5M
Dividend yield
0.00%
Volume
6,728
Avg. volume
19,758
P/E ratio
-.80
BioLineRx Ltd. American Depositary Shares News
Details
Daily high
$3.60
Daily low
$3.50
Price at open
$3.60
52 Week High
$35.60
52 Week Low
$2.30
Market cap
13.5M
Dividend yield
0.00%
Volume
6,728
Avg. volume
19,758
P/E ratio
-.80